| 70-gene signature as an aid to treatment decisions in early-stage breast cancer F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ... New England Journal of Medicine 375 (8), 717-729, 2016 | 1859 | 2016 |
| International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer H Wildiers, P Heeren, M Puts, E Topinkova, MLG Janssen-Heijnen, ... Journal of clinical oncology 32 (24), 2595, 2014 | 1647 | 2014 |
| Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ... The Lancet Oncology 19 (1), 27-39, 2018 | 902 | 2018 |
| A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer P Farmer, H Bonnefoi, P Anderle, D Cameron, P Wirapati, V Becette, ... Nature medicine 15 (1), 68-74, 2009 | 732 | 2009 |
| Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study N Penel, BN Bui, JO Bay, D Cupissol, I Ray-Coquard, ... Journal of Clinical Oncology 26 (32), 5269-5274, 2008 | 700 | 2008 |
| Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer … L Biganzoli, H Wildiers, C Oakman, L Marotti, S Loibl, I Kunkler, M Reed, ... The lancet oncology 13 (4), e148-e160, 2012 | 635 | 2012 |
| 21-gene assay to inform chemotherapy benefit in node-positive breast cancer K Kalinsky, WE Barlow, JR Gralow, F Meric-Bernstam, KS Albain, ... New England Journal of Medicine 385 (25), 2336-2347, 2021 | 465 | 2021 |
| Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized … JY Pierga, FC Bidard, C Mathiot, E Brain, S Delaloge, S Giachetti, ... Clinical Cancer Research 14 (21), 7004-7010, 2008 | 447 | 2008 |
| Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology H Wildiers, I Kunkler, L Biganzoli, J Fracheboud, G Vlastos, ... The lancet oncology 8 (12), 1101-1115, 2007 | 422 | 2007 |
| Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review E Luporsi, F Andre, F Spyratos, PM Martin, J Jacquemier, ... Breast cancer research and treatment 132, 895-915, 2012 | 417 | 2012 |
| Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients A Yovine, M Riofrio, JY Blay, E Brain, J Alexandre, C Kahatt, A Taamma, ... Journal of Clinical Oncology 22 (5), 890-899, 2004 | 376 | 2004 |
| High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for … JY Pierga, D Hajage, T Bachelot, S Delaloge, E Brain, M Campone, ... Annals of oncology 23 (3), 618-624, 2012 | 319 | 2012 |
| Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer … R Gray, R Bradley, J Braybrooke, Z Liu, R Peto, L Davies, D Dodwell, ... The lancet 393 (10179), 1440-1452, 2019 | 314 | 2019 |
| Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer FC Bidard, C Mathiot, S Delaloge, E Brain, S Giachetti, P De Cremoux, ... Annals of Oncology 21 (4), 729-733, 2010 | 304 | 2010 |
| High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas. A Le Cesne, E Antoine, M Spielmann, T Le Chevalier, E Brain, ... Journal of Clinical Oncology 13 (7), 1600-1608, 1995 | 276 | 1995 |
| First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity C Brignone, M Gutierrez, F Mefti, E Brain, R Jarcau, F Cvitkovic, ... Journal of translational medicine 8, 1-11, 2010 | 273 | 2010 |
| Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort E Gobbini, M Ezzalfani, V Dieras, T Bachelot, E Brain, M Debled, W Jacot, ... European journal of cancer 96, 17-24, 2018 | 268 | 2018 |
| Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up N Penel, A Le Cesne, BN Bui, D Perol, EG Brain, I Ray-Coquard, ... Annals of Oncology 22 (2), 452-457, 2011 | 256 | 2011 |
| Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm … F Montemurro, S Delaloge, CH Barrios, R Wuerstlein, A Anton, E Brain, ... Annals of Oncology 31 (10), 1350-1358, 2020 | 251 | 2020 |
| 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age M Piccart, LJ van't Veer, C Poncet, JMNL Cardozo, S Delaloge, JY Pierga, ... The Lancet Oncology 22 (4), 476-488, 2021 | 231 | 2021 |
